Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Virol J ; 8: 54, 2011 Feb 08.
Artigo em Inglês | MEDLINE | ID: mdl-21303494

RESUMO

There is worldwide concern over the possibility of a new influenza pandemic originating from the highly pathogenic avian H5N1 influenza viruses. We herein demonstrate that functional air filters impregnated with ostrich antibodies against the hemagglutinin of the H5N1 virus protect chickens from death by H5N1 transmission. These results suggest that the use of ostrich antibody-impregnated filters might be a powerful way to prevent the transmission of H5N1.


Assuntos
Microbiologia do Ar , Anticorpos Antivirais/metabolismo , Desinfecção/métodos , Filtração/métodos , Virus da Influenza A Subtipo H5N1/isolamento & purificação , Influenza Aviária/prevenção & controle , Filtros Microporos/virologia , Animais , Galinhas , Struthioniformes
2.
Biomaterials ; 145: 256-265, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28915391

RESUMO

Alternatives to syringe-based administration are considered for vaccines. Intradermal vaccination with dissolvable microneedle arrays (MNA) appears promising in this respect, as an easy-to-use and painless method. In this work, we have developed an MNA patch (MNAP) made of hydroxyethyl starch (HES) and chondroitin sulphate (CS). In swines, hepatitis B surface antigen (HBsAg) formulated with the saponin QS-21 as adjuvant, both incorporated in HES-based MNAP, demonstrated the same level of immunogenicity as a commercially available aluminum-adjuvanted HBsAg vaccine, after two immunizations 28 days apart. MNAP application was associated with transient skin reactions (erythema, lump, scab), particularly evident when the antigen was delivered with the adjuvant. The thermostability of the adjuvanted antigen when incorporated in the HES-based matrix was also assessed by storing MNAP at 37, 45 or 50 °C for up to 6 months. We could demonstrate that antigenicity was retained at 37 and 45 °C and only a 10% loss was observed after 6 months at 50 °C. Our results are supportive of MNAP as an attractive alternative to classical syringe-based vaccination.


Assuntos
Antígenos Virais/metabolismo , Antígenos de Superfície da Hepatite B/metabolismo , Agulhas , Temperatura , Animais , Feminino , Imunidade Humoral , Imunização , Imunoglobulina G/metabolismo , Reprodutibilidade dos Testes , Pele/imunologia , Pele/patologia , Sus scrofa
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa